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Abstract
Background: Extracellular stimuli induce gene expression responses through intracellular signaling mediators. The
p38 signaling pathway is a paradigm of the mitogen-activated protein kinase (MAPK) family that, although originally
identified as stress-response mediator, contributes to establishing stem cell differentiation fates. p38α is central for
induction of the differentiation fate of the skeletal muscle stem cells (satellite cells) through not fully characterized
mechanisms.
Methods: To investigate the global gene transcription program regulated by p38α during satellite cell differentiation
(myogenesis), and to specifically address whether this regulation occurs through direct action of p38α on gene
promoters, we performed a combination of microarray gene expression and genome-wide binding analyses. For
experimental robustness, two myogenic cellular systems with genetic and chemical loss of p38α function were used:
(1) satellite cells derived from mice with muscle-specific deletion of p38α, and (2) the C2C12 murine myoblast cell line
cultured in the absence or presence of the p38α/β inhibitor SB203580. Analyses were performed at cell proliferation
and early differentiation stages.
Results: We show that p38α binds to a large set of active promoters during the transition of myoblasts from
proliferation to differentiation stages. p38α-bound promoters are enriched with binding motifs for several transcription
factors, with Sp1, Tcf3/E47, Lef1, FoxO4, MyoD, and NFATc standing out in all experimental conditions. p38α association
with chromatin correlates very well with high levels of transcription, in agreement with its classical function as an
activator of myogenic differentiation. Interestingly, p38α also associates with genes repressed at the onset of
differentiation, thus highlighting the relevance of p38-dependent chromatin regulation for transcriptional activation
and repression during myogenesis.
Conclusions: These results uncover p38α association and function on chromatin at novel classes of target genes
during skeletal muscle cell differentiation. This is consistent with this MAPK isoform being a transcriptional regulator.
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Background
Cellular signaling is essential for the cells’ ability to re-
spond to the environment by integrating external cues
to intracellular mediators and effectors. Activation of
mitogen-activated protein kinases (MAPKs) constitutes
a paradigm of intracellular signaling. p38, a subgroup of
the MAPKs, was initially identified as a transducer of
the response to inflammatory and environmental stress
conditions. There are four p38 MAPKs in mammals:
MAPK14 (p38α), MAPK11 (p38β), MAPK12 (p38γ), and
MAPK13 (p38δ) [1, 2]. Activation of these MAPKs has
also been associated with the differentiation capacity of
several stem cell types. In particular, p38 plays an inte-
gral role in the fate decision of stem cells of the skeletal
muscle lineage [3, 4]. Muscle stem cells (also called sat-
ellite cells), established early during development, are
marked by the expression of the paired-box transcription
factor Pax7, and have as principal mission sustaining
skeletal muscle regeneration [5, 6]. When stimulated by
an injury or disease, these normally quiescent stem cells
are activated, begin to proliferate as myoblasts and, sub-
sequently, they either exit the cell cycle, differentiate and
fuse to form new fibers (or repair damaged ones), or
self-renew to replenish the satellite cell pool. In vitro
studies using cellular models (satellite cell-derived pri-
mary myoblasts or myoblast cell lines) that recapitulate
the myogenic stages of the in vivo regeneration process,
in combination with the chemical inhibitor of p38α/
p38β SB203580, have shown an active participation of
the p38 MAPK pathway in each stage, with a principal
function as a regulator of the myoblast proliferation-to-
differentiation transition, by inducing cell cycle with-
drawal and expression of muscle differentiation-specific
genes [3, 4, 7–9].
Consistent with their kinase activity, several transcrip-
tion factors can be directly phosphorylated by p38α/β
MAPKs, including E47, the dimerization partner of the
master myogenic regulatory factors (MRFs) of the MyoD
family, and MEF2, a transcription factor cooperating
with the MRFs in myogenic gene transcription; these
phosphorylation events have a profound effect on gene
expression as they modulate the activity of MyoD-E47
and MEF2 on muscle-specific promoters [3, 10–14]. Fur-
thermore, by phosphorylating the chromatin-associated
protein BAF60c, p38α/β kinases contribute to the assem-
bly of the myogenic transcriptosome on the chromatin of
muscle loci by promoting the recruitment of SWI/SNF
chromatin remodeling complex [15–17] and ASH2L-
containing mixed-lineage leukemia (MLL) methyltransfer-
ase complex [18, 19]. Through phosphorylation, p38α also
recruits SNF2-related CBP activator protein (SRCAP) sub-
unit p18Hamlet to muscle loci, which is in turn required for
H2A.Z accumulation and transcriptional activation [20].
p38α-mediated phosphorylation of Ezh2, the enzymatic
subunit of polycomb repressor complex 2 (PRC2) also reg-
ulates the expression of Pax7, thus controlling the deci-
sion of satellite cells to proliferate or differentiate [21]. By
contrast, p38γ represses MyoD transcriptional activity by
direct phosphorylation, via association with the H3K9
methyltransferase KMT1A, thereby also influencing this
myogenic decision [22]. Thus, the p38 MAPK pathway
can either activate or repress gene expression in satellite
cells, depending on the engagement of specific p38 iso-
forms. Notably, in vitro studies using satellite cells lacking
individual p38 family members showed that the four p38
isoforms are not completely redundant during myogenesis
[7, 23, 24], and uncovered a predominant role of the p38α
isoform in myogenic differentiation [7, 23, 24], with p38γ
signaling contributing to proliferation by preventing pre-
mature differentiation [22], whereas p38β and p38δ ap-
peared rather dispensable for these processes [7, 23].
Because muscle regeneration in vivo can proceed quite ef-
fectively in the absence of the p38γ isoform [23], but is de-
fective in the absence of p38α [25], p38α is indeed
acknowledged as the master kinase for reprogramming
gene expression during the proliferation-to-differentiation
switch of satellite cells in vitro and in vivo.
Studies in yeast have shown that the p38 MAPK
homolog, Hog1, activates transcription in response to
osmotic stress by acting directly at chromatin [26, 27].
Likewise, mammalian p38 MAPK can bind to some
stress-responsive loci upon exposure to several types of
stresses, emphasizing that the association of the MAPK
with target promoters can stimulate gene expression
[28]. In skeletal myoblasts, p38α has also been found to
bind certain muscle-specific genes such as myogenin,
muscle creatine kinase, and myosin heavy chain during
the process of myogenic differentiation [15, 21]. How-
ever, whether p38α can regulate gene transcription glo-
bally during myogenesis via direct action on gene
promoters is unknown. Here, we assessed the genome-
wide enrichment of the p38α MAPK isoform, coupled to
the p38α-dependent global gene expression program,
during the switch of myogenic cells from proliferation-
to-differentiation stages. Our findings enlarge the picture
of p38α MAPK as an important coordinator of myogenic
gene expression through direct association to chromatin.
Methods
Cell culture
The C2C12 myoblast cell line was cultured at 37 °C in
5 % CO2 in Dulbecco’s Modified Eagle’s Medium
(DMEM; Invitrogen) with 10 % fetal bovine serum (FBS)
and supplemented with antibiotics (100 U/ml penicillin
and 100 μg/ml streptomycin (growth medium (GM)).
Satellite cells were obtained from p38α-deficient and
WT mouse muscles, as described in [7] and their
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myoblast progeny was maintained on collagen-coated
dishes in Ham’s F10 medium supplemented with 20 %
FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, and
5 ng/ml bFGF (GM). These cells are referred to as satel-
lite cells throughout the study. Experiments were per-
formed by plating cells on Matrigel™ (BD Biosciences)
Basement Membrane Matrix-coated dishes. To induce
differentiation in both primary and C2C12 myoblasts,
GM was replaced by differentiation medium (DM)
(DMEM supplemented with 2 % horse serum, 2 mM L-
glutamine, 100 U/ml penicillin, and 100 μg/ml strepto-
mycin) at myoblast subconfluence. For p38α/β MAPK
inhibition studies, SB203580 was added directly to DM
at a final concentration of 5 μM.
Western blotting
Western blotting was performed as described previously
[7]. Antibodies used were phospho-p38 (Thr180/Tyr182)
(Cell Signaling 9211) and Tubulin (Sigma T-6199).
Immunofluorescence in C2C12 myoblasts
C2C12 cells were fixed in PFA 4 % for 10 min at room
temperature, washed with PBS, and permeabilized with
0.5 % Triton X-100 in PBS during 10 min. Cells were in-
cubated with blocking solution (10 % goat serum, 10 %
BSA in PBS) for 1 h at room temperature and then over-
night at 4 °C with p38α antibody (Santa Cruz Biotech-
nology sc-535) diluted 1/50 in blocking solution. After
three washes in PBS-Tween 0.025 %, cells were further
incubated with goat anti-rabbit conjugated with Alexa-
Fluor 488 (Invitrogen; 1/250) for 1 h. DAPI (1/1000) was
used to label DNA, and the slides were mounted with
Mowiol. Imaging was carried out with TCS-SPE confocal
microscope (Leica) using LAS AF software.
RNA isolation, reverse transcription (RT), and quantitative
PCR (qPCR)
Total RNA from proliferating and differentiating myo-
blasts was isolated with TriPure Isolation Reagent and
quantified with Nanodrop. M-MLV reverse transcriptase
(Promega) was used to synthesize cDNAs from the total
RNA (1 μg) following the manufacturer’s recommenda-
tions. RT-qPCR reactions were performed with SYBR
Green in 384-well plates using the Roche LC-480 cycler
(Roche Applied Science). The mRNA expression of
target genes was normalized to L7 expression, and the
data are represented as the mean ± SD of three inde-
pendent experiments. Primer sequences are listed in
Additional file 1: Table S2.
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed from approximately 5*106
C2C12 cells per experiment. Briefly, cells were cross-
linked with 1 % formaldehyde for 10 min at room
temperature, and the crosslinking was then quenched
with 0.125 M glycine for 5 min. Cross-linked cells were
washed twice with cold PBS, resuspended in 600 μl of
SDS lysis buffer (1 % SDS, 10 mM EDTA, 50 mM Tris-
HCl, pH 8.1, plus protease inhibitors) and incubated on
ice for 10 min. Cell lysate was sonicated to shear chro-
matin to an average length of 200–500 bp using a Diage-
node Bioruptor. Sonicated samples were centrifuged at
13,000 rpm for 10 min and the chromatin concentration
of the supernatant was quantified. Seventy microgram of
chromatin were diluted 10-fold in ChIP dilution buffer
(0.01 % SDS, 1.1 % Triton X-100, 1.2 mM EDTA,
167 mM NaCl, 16.7 mM Tris-HCl, pH 8.1, plus protease
inhibitors) and immunoprecipitated overnight at 4 °C
with 3 μg of p38α antibody (Cell Signaling 9218) and
1 μg of MyoD and Mef2 antibodies (Santa Cruz Biotech-
nology sc-304 and sc-13917, respectively) or control IgG
antibody (Cell Signaling 2729). Twenty microliter of
Magna ChIP Protein A + G Magnetic Beads (Millipore)
were added and incubated for 1 h at 4 °C. Beads were
successively washed with 1 ml of different buffers: low-
salt immune complex wash buffer (0.1 % SDS, 1 % Tri-
ton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1,
150 mM NaCl), high-salt immune complex wash buffer
(0.1 % SDS, 1 % Triton X-100, 2 mM EDTA, 20 mM
Tris-HCl, pH 8.1, 500 mM NaCl), LiCl immune complex
wash buffer (0.25 M LiCl, 1 % NP40, 1 % deoxycholate,
1 mM EDTA, 10 mM Tris-HCl, pH 8.1), and TE (1 mM
EDTA, 10 mM Tris-HCl, pH 8.0). To elute the immuno-
complexes, beads were incubated twice in elution buffer
(1 % SDS, 100 mM NaHCO3) for 15 min at room
temperature. The crosslinking was reverted by further
incubating the DNA at 65 °C overnight. DNA was
extracted with phenol/chloroform, ethanol-precipitated
and resuspended in 80 μl of H2O for further analysis.
Bound fraction and input were analyzed by PCR and
qPCR using specific primer sets for each of the analyzed
promoters (see Additional file 1: Table S2). Relative re-
cruitment is calculated as the amount of amplified DNA
normalized to input and relative to values from control
IgG immunoprecipitation, which were set as 1 in each
calculation.
Microarray analysis
RNA samples were collected from C2C12 cells (proliferat-
ing and differentiated for 24 h ± the p38α/β inhibitor
SB203580) and primary myoblasts from WT and p38α-
deficient mice in proliferation conditions and at 24 h of
differentiation. Transcriptome analysis was performed
using the 44K Whole-Mouse Genome (Agilent), and the
RNA labeling and hybridization process was performed
following the manufacturer’s instructions. Microarray ana-
lysis was performed with three samples per condition; for
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the primary myoblasts, each sample was a pool of three
independent cultures. Moreover, and to avoid bias labeling
artifacts, dye swap experiments were performed. Fluores-
cent images were obtained with an Agilent G2565BA
scanner. Microarray images were quantified using Gene-
Pix software. Only spots with signal intensities twice above
the local background, not saturated, and not flagged by
GenePix were considered reliable and used for subsequent
analysis. Extracted intensities were subtracted from the
local background, and the log2 ratios were normalized in
an intensity-dependent fashion by global LOWESS. For
normalization and differential expression analysis, we used
Bioconductor [29] (www.bioconductor.org) package
LIMMA [27] for Agilent two-color microarray data. For
differential expression analysis, we filtered for genes that
show at least Log2FC 0.25 (≥+0.25 for upregulation
and ≤−0.25 for downregulation).
ChIP-on-chip analysis
Chromatin immunoprecipitation was performed in quadru-
plicate from independent C2C12 cultures of each condition.
Each sample was cross-linked, and immunoprecipitation
was performed as described above using p38α-specific anti-
bodies (Cell Signaling). To avoid the high variability de-
tected with p38α antibody, immunoprecipitated and input
DNA were pooled, labeled by ligation-mediated PCR with
Cy5 and Cy3 fluorescent dyes, respectively. Pools of labeled
DNA were hybridized to a 244K Mouse Promoter Chip
(Agilent) following the manufacturer’s instructions. The
array was scanned and analyzed with GenePix software as
explained above. Genome-wide location data were normal-
ized, and the ratio of immunoprecipitated to input DNA
was determined for each probe. For each array, a confidence
value (P value) was calculated for each probe using an error
model as explained before [27]. Briefly, probes that scored
significantly above background were then combined into
probe sets of three probes if they passed the following filter:
the center probe in the probe set has a single point P value
<0.001, one of the flanking probes has a single point
P value <0.01, and the three probes combined have a
P value <0.001. For binding peaks that typically span over
transcribed regions and thus span over several probes, the
following filter was used: the center probe in the probe set
has a single point P value <0.005, the three probes
combined have a P value <0.0001 and one of the flanking
probes has a combined P value <0.001. Bound probe sets
that overlapped were collapsed into bound regions. For
each bound region, the closest ORF was then assigned
and the maximum ChIP enrichment identified (see
Additional file 2: Table S1).
Bioinformatic and statistical analysis
Gene ontology analysis was performed using DAVID func-
tional annotation clustering [30]. Gene set enrichment
analysis (GSEA) was performed using the default parame-
ters [31]. Venn diagrams were generated using The BEG
Ugent tool (http://bioinformatics.psb.ugent.be/webtools/
Venn/). Volcano plots of gene expression and statistical
analysis data were performed using Graphpad Prism soft-
ware. Quantitative data displayed as histograms are
expressed as means ± standard error of the mean (rep-
resented as error bars). Results from each group were
averaged and used to calculate descriptive statistics.
Mann–Whitney U test (independent samples) was used
for pairwise comparisons among groups at each time
point. Statistical significance was set at a P value <0.05.
Mice
Mice carrying the floxed p38α, allele were generated by
Boehringer Ingelheim Pharmaceuticals Inc. (Ridgefield,
USA). Floxed p38α mice were crossed to More-CRE
knock-in mice to obtain p38α knockout mice. All animal
experiments and isolation of satellite cells from wild type
and knockout mice [7] were approved by the ethics
committee of the Barcelona Biomedical Research Park
(PRBB) and by the Catalan Government and used sex-,
age- and weight matched littermate animals.
Results
Consequences of genetic and chemical p38α inhibition on
the gene expression program of differentiating myoblasts
Because p38α controls the transition of myoblasts from
proliferating to differentiating stages, we aimed to study
specifically the changes in gene expression occurring
during this transition (Fig. 1a). To increase the robust-
ness of the experimental strategy, we used distinct myo-
genic cellular models and p38α-inhibiting alternatives:
satellite cells obtained from muscle of wild type (WT)
mice or mice with deletion in p38α [7], and the C2C12
myoblast cell line, cultured in the absence or presence of
the p38α/β inhibitor SB203580 (SB) (Fig. 1a). Because
the p38β isoform is not (or lowly) expressed in C2C12
myoblasts (Additional file 3: Figure S1), the inhibitory
action of SB203580 on these cells will likely be attribut-
able to p38α. Genome-wide microarrays of both types of
cells (with/without genomic or chemical p38α-inhibitory
conditions) in proliferation (growth medium (GM)) and
early differentiation (24 h in differentiation medium
(DM)) states were performed.
Through these analyses, we identified a large number
of genes regulated by p38α (Fig. 1b; Additional file 2:
Table S1), being this regulation particularly marked at
the early 24 h myoblast differentiation stage. Gene ontol-
ogy (GO) analysis using DAVID functional annotation
clustering of the GO terms showed a downregulation in
expression of muscle-differentiation-specific genes for
satellite cells lacking p38α, whereas genes involved in
proliferation and cell-cycle progression were upregulated
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Fig. 1 (See legend on next page.)
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(Fig. 1c). p38α signaling in satellite cells also ap-
peared to regulate multiple genes and transcription
factors that had not been previously related to myo-
genesis, for example, genes encoding signaling pro-
teins and genes involved in proteolysis or DNA
metabolism and damage. In contrast, SB treatment
of C2C12 cells caused downregulation of genes re-
lated to secretory pathways and cytoskeleton
organization, whereas the expression of genes related
to transcription, chromatin organization, or ion
binding was upregulated (Fig. 1d). Of note, the cell-
cycle-related genes that were found upregulated in
p38α-deficient satellite cells after 24 h in DM
remained unchanged in SB-treated C2C12 cells at
the same time point; however, SB-treated C2C12
cells showed upregulation of these proliferation-
related genes at a later time point in DM (i.e., 48 h),
according to the recently published data [8], suggest-
ing a delay in the cell-cycle exit of C2C12 immortal-
ized myoblasts, compared to primary satellite cells,
in differentiation-promoting conditions. Of the p38α-
regulated genes in both experimental conditions,
only 102 and 169 genes were commonly up- and
downregulated, respectively, in SB-treated C2C12
myoblasts and p38α-deficient satellite cells (Fig. 1e).
Thus, the stringency imposed by the use of distinct
muscle cell models and p38-inhibiting strategies
allowed the identification of a robust list of bona fide
genes dependent on p38α at the onset of myogenic
differentiation (Additional file 2: Table S1). GO ana-
lysis of genes commonly regulated in SB-treated
C2C12 cells, and p38α-deficient satellite cells at 24 h
DM showed that the expression of muscle
differentiation-specific genes is commonly downregu-
lated in both types of cells in the absence of p38α
signaling (Fig. 1f ). In contrast, genes commonly up-
regulated in both conditions were related to the tran-
scription and cell motion processes (Fig. 1f ).
A further comparison of the expression arrays from
C2C12 myoblasts in DM for 24 and 48 h (in the absence
or presence of SB) revealed a dramatic difference in both
time points: only 20 % of the genes upregulated by the
48 h DM + SB treatment were also upregulated at the
earlier DM + SB 24 h time point (Fig. 1g); likewise, only
30 % of the downregulated genes at the 48 h DM + SB
treatment were common with the 24 h DM + SB condi-
tions. Thus, p38α regulates the muscle differentiation
gene program in C2C12 myoblasts with distinct kinetics
(i.e., p38α-dependent early and late myogenic genes)
(Fig. 1g). Interestingly, comparison of the 24 and 48 h
DM + SB C2C12 cells with the 24 h DM p38α-deficient
satellite cells demonstrated that, in addition to cell-cycle
exit, the kinetics of the p38α-dependent proliferation-to-
differentiation gene expression transition program differ
between both cell types; indeed, this transition was faster
in satellite cells, as shown by the similar number of com-
mon p38α-regulated genes in the 24 h-DM satellite-cell
time point and in C2C12 cells at both time points
(Fig. 1h). It is probable that the faster differentiation kin-
etics might be related to the more rapid and pronounced
activation of p38 MAPK signaling in satellite cells than
C2C12 cells in the GM to DM transit conditions
(Fig. 1a).
We next performed qPCR analysis of p38α-deficient
and WT satellite cells (Fig. 2a) and C2C12 myoblasts-
treated or not with SB-treated (Fig. 2b) to validate the
gene expression microarray results. We confirmed that
transcripts belonging to different gene networks are
regulated by p38α (in both genetic and chemical in-
hibitory settings), including muscle-specific and cell-
cycle-regulatory genes, multiple transcription factors,
and genes encoding signaling proteins.
In order to identify transcription factor binding sites
of genes regulated by p38α, we performed a gene set en-
richment analysis (GSEA) in both types of cells and
p38α-inhibitory conditions. The analysis showed that
(See figure on previous page.)
Fig. 1 Gene expression analysis of p38α-deficient satellite cells and C2C12 cells treated with SB203580 (SB). a Satellite cells and C2C12 myoblasts
were cultured in growth medium (GM) until subconfluent and then shifted to differentiation medium (DM) at the indicated time points. (left)
Representative pictures of WT and p38α-deficient satellite cells 24 and 48 h in DM, and relative expression levels of differentiation-specific genes
Myog and Myh1 analyzed by qPCR. (right) Activation of p38 was analyzed in both cells types by Western Blot using an anti-phospho-p38 antibody
and expression of p38α in satellite cells derived from WT, and p38α-deficient mice was analyzed by qPCR (right panel). b Volcano plot showing
differentially expressed genes in p38α-deficient versus WT satellite cells in GM, and DM for 24 h (top and middle panel, respectively) and in SB-treated
C2C12 cells versus untreated (bottom panel). Downregulated and upregulated genes are marked in green and red, respectively. c Gene ontology (GO)
analysis of differentially expressed genes in p38α-deficient satellite cells over WT at 24 h DM was performed using DAVID. Enriched GO annotations of
downregulated and upregulated genes are shown in green and red, respectively. d As in (c) GO analysis of differentially expressed genes in C2C12
myoblasts (SB-treated versus untreated) at 24 h in DM. e Non-proportional 2-way Venn diagram comparing the effect in gene expression of p38α-
deficient satellite cells at 24 h in DM (over WT) with the effect of chemical inhibition of p38α in C2C12 cells (SB treated over untreated). Only 102 and 169
genes are commonly upregulated and downregulated, respectively. f As in (d) GO analysis of genes that are commonly upregulated and downregulated
in both C2C12 cells treated or not with SB and in satellite cells after 24 h in DM. g Comparison between expression arrays performed in C2C12 cells
treated with SB203580 at 24 and 48 h in DM. The non-proportional 2-way Venn diagrams show the number of upregulated and downregulated genes
in C2C12 cells treated with SB203580 over untreated cells. h Comparison between expression arrays performed in C2C12 cells treated with SB203580
(24 and 48 h DM) and p38α-deficient satellite cells
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genes regulated by p38α have enriched binding sites for
different transcription factors, such as Sp1, Lef1, Tcf3/
E47, FoxO4, Pax4, MyoD, or NFATc (Fig. 3), and most
of them are common in all conditions analyzed (satellite
cells 24 h DM, C2C12 24 h DM, and 48 h DM; up-
and downregulated). Interestingly, E2F-binding sites
are enriched exclusively in p38α-regulated genes in
p38α-deficient satellite cells at 24 h DM, and in C2C12
cells at 48 h (but not at 24 h) DM, consistent with the
dysregulation of the cell-cycle/proliferation gene program.
Identification of p38α-chromatin binding sites at the
myogenic proliferation-to-differentiation switch
To investigate whether p38α regulates global gene tran-
scription at the myoblast proliferation-to-differentiation
transition by directly acting at chromatin, we investigated
the association of p38α to gene promoters in proliferating
(GM) and early differentiating myoblasts (24 h DM) by
ChIP-on-chip analysis using a p38α-specific antibody.
Following our transcriptome analysis, and to focus on the
early events of differentiation and p38α activation, we
performed our analysis in C2C12 cells. The obtained ChIP-
on-chip data revealed that the binding of p38α is markedly
enriched at many gene promoters both in proliferation and
early differentiation stages, consistent with its localization
in the nuclear compartment in these two conditions (Add-
itional file 3: Figure S2). A stringent analysis unveiled 2268
p38α-bound genes in myoblasts in GM and 1434-bound
genes in DM. We detected a high overlap between GM and
DM as more than 1000 genes were bound by p38α in both
myogenic conditions (Fig. 4a). A general clustering analysis
of genes bound by p38α in C2C12 cells identified genes that
could be grouped in five clusters according to the pattern
of binding along the promoter (Fig. 4b). Interestingly, clus-
ter 1 included many transcription factors, developmental
regulators, and muscle-related genes, whereas cluster 5 was
enriched in protein transport, phosphorylation, and cell
cycle-related genes. GO analysis revealed common p38α-
bound genes enriched in positive and negative regulators of
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Satellite cells
C2C12
Fig. 2 Validation of the p38α-dependent genes from expression arrays. a p38α-regulated genes were validated by qPCR in satellite cells derived
from WT and p38α-deficient mouse muscles after 24 h in DM. b Genes regulated by chemical inhibition of p38α were validated by qPCR in differentiating
C2C12 myoblasts (24 h DM) treated or not with SB. Different gene networks are regulated by p38α: muscle-specific and cell-cycle regulator genes,
transcription factors, and genes encoding signaling proteins. Values are mean ± SEM of three independent experiments. Non-parametric
Mann–Whitney U test was used for comparisons (P values <0.05)
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organization, and serine/threonine and protein kinase-
related genes; genes bound only in proliferative conditions
were enriched in Golgi apparatus genes, positive regulators
of transcription and further enriched in Wnt signaling
molecules. Interestingly, genes bound only in differ-
entiating conditions were enriched in glycoproteins
and membrane proteins, and in general, but negative
regulators of transcription (positive general tran-
scriptional regulators were not enriched) (Fig. 4c).
Moreover, GSEA analysis of transcription factor
binding sites in the p38α-bound genes identified
enriched binding sites for nearly the same transcrip-
tion factors found in p38α-regulated genes obtained
in the expression microarrays, for example: Sp1,
Lef1, Tcf3/E47, FoxO4, Pax4, MyoD, or Nfatc
(Fig. 4d). Since some of these transcription factors
have been described as phosphorylation substrates of
p38 MAPK in different model systems, including
Sp1 [32, 33] Tcf3/E47 [12], NFATC4 [34], or E2F4
[35], and the pattern of p38α recruitment to genes is
mostly restricted to proximal promoter regions, it is
tempting to propose that p38α will likely regulate
the myoblast proliferation-to-differentiation transi-
tion mainly through these transcription factors.
Of note, genome-wide binding analysis of p38α in experi-
mental conditions of myogenic differentiation, where p38α is
expressed but its kinase activity is inhibited (C2C12 cells in
DM + SB), revealed that the kinase activity was not required
for p38α recruitment to chromatin; on the contrary, at the
genome level, there was a generally increased occupancy
Factor Genes p-value Factor Genes p-value Factor Genes p-value
Sp1 338 5.32E-88 Sp1 104 1.46E-28 E2f (10) 15 5.81E-13
Lef1 (2) 264 8.29E-82 Lef1 (2) 75 2.74E-22 E2f (Tfbp1) 14 1.33E-11
Tcf3 (E12) 258 4.42E-57 Foxo4 73 5.87E-20 Lef1 (2) 27 9.20E-11
Foxo4 230 3.99E-56 81 6.16E-20 E2f4 12 2.29E-09
Maz:Myc 236 5.79E-52 Srebf1 31 7.92E-16 Sp1 38 3.61E-08
Nfatc 206 3.01E-48 Nfatc 62 2.03E-15 Tcf3 (E12) 34 5.51E-08
Myc (2) 140 1.99E-43 Pax4 47 1.68E-13 Pax4 22 4.59E-07
E2f (13) 65 6.89E-40 Ap4 51 3.29E-13 Maz:Myc 30 7.78E-07
E2f (Tfbp1) 64 1.8E-38 Maz:Myc 64 6.17E-13 Nfil3 10 8.32E-07
E2f (Tfbp2) 64 1.8E-38 Foxf2 37 3.82E-12 Sox9 11 1.75E-06
Pax4 136 2.55E-30 Myod 37 4.47E-12 Nfatc 26 2.26E-06
Foxf2 107 1.27E-27 Tcf8 33 2.37E-11 Atf2 8 3.07E-06
Ets2 115 4.64E-26 Myc 38 2.66E-11 Pou2f1 9 8.84E-06
Foxa1 90 8.16E-25 Ets2 38 1.11E-10 Foxo4 26 9.92E-06
Ddit3 (Chop) 50 1.03E-24 Atf3 25 7.25E-10 Foxf2 16 1.34E-05
Ap4 134 1.47E-22 Zfp161 17 7.56E-10 Ets2 17 2.75E-05
Sox9 59 1.1E-21 Foxa1 29 1.50E-09 Gata1 8 3.00E-05
Ap1 107 8.36E-21 E4f1 27 2.22E-09 Cdc5 8 4.09E-05
CEBPa 50 1.03E-24 Ipf1 17 2.72E-09 Pax2 8 4.32E-05
MyoD 94 2.93E-20 Runx1 17 2.88E-09 Pcbp1 8 4.57E-05
p53 43 1.01E-17 Creb1 17 4.29E-09 Ipf1 8 4.57E-05
Factor Genes p-value Factor Genes p-value Factor Genes p-value
Ap4 (3) 231 4.38E-98 Tcf3 147 7.9E-45 Ap4 (2) 58 1.1E-24
276 1.44E-85 Maz:Myc 130 7.2E-38 Sp1 76 5.4E-22
Foxo4 216 1.67E-61 Sp1 149 1.3E-37 Nfatc 58 4.2E-20
Sp1 262 7.34E-61 Nfatc 108 3.6E-31 Maz:Myc 62 5.2E-19
Mef2 (6) 124 6.84E-60 Ap1 (3) 80 1.8E-29 Lef1 (2) 57 1.2E-18
Maz:Myc 220 1.34E-56 Ap4 (2) 93 4.9E-29 Tcf3 63 9E-18
Myod (3) 137 3.61E-56 Foxo4 103 3.1E-25 Pax4 45 9.1E-18
Lef1 (2) 196 5.56E-52 Pax4 79 1E-24 Srf 20 4.7E-16
Nfatc 184 3.32E-47 Lef1 (2) 96 1E-22 Ap1 39 1.6E-15
Meis1 113 8.85E-43 Ets2 67 2.4E-21 Mef2 (2) 29 4.5E-12
Pax4 138 9.93E-40 Myod 58 6.2E-19 Tead1 22 6.2E-12
Nf1 99 1.11E-37 Meis1 50 7.9E-16 Tcf8 28 4.5E-10
Ap1 113 2.13E-30 Mef2a 45 2.2E-15 Evi1 15 3.9E-10
Vsx1 92 1.05E-28 Foxf2 48 6.7E-13 Foxo4 43 1.1E-09
Tead1 58 4.87E-25 Tcf8 44 8E-13 Foxf2 27 1.8E-09
Myc 97 6.1E-24 Myc 51 9.9E-13 Ets2 29 3.6E-09
Tcf8 47 8.74E-24 Srf 24 1.1E-12 Nf1 23 6.6E-09
Tbp 43 3.19E-21 Atf1 23 3.1E-12 Ap4 13 1.8E-08
Ap4 42 1.1E-19 Nf1 40 9.8E-12 Meis1 24 1.8E-08
Srf 38 1.33E-18 Err1 49 1.7E-11 Myod 25 3.6E-08
Enriched transcription factor binding sites
Up Primaries 24h Up C2C12 24h + SB Up C2C12 48h + SB
Down Primaries 24h Down C2C12 24h + SB Down C2C12 48h + SB
Tcf3 (E12) (2)   
Tcf3 (E12) (2)
Fig. 3 Table showing transcription factor binding sites of p38α-regulated genes. Analyses of DNA-binding elements present in promoters were
performed using GSEA. Red numbers indicate number of times that the factor appeared in the analysis with different DNA-binding elements, the
highest P value element is shown. Unknown binding elements have been omitted
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signal on promoters when cells were treated with the p38α/β
inhibitor, as exemplified by full chromosome 11 and the pro-
moter of Wnt9a, one of the p38α-regulated genes (Fig. 5).
This indicates that recruitment of p38α to certain gene pro-
moters is independent of its kinase activity, although the
underlying reason is currently unknown.
Identification of genes bound and regulated by p38α
during early myogenic differentiation
To complete the identification of the genes bound and
regulated by p38α at the myogenic proliferation-to-
differentiation switch, we crossed the two data sets: the
expression microarray and the ChIP-on-chip data. We
Fig. 4 ChIP-on-chip analysis for p38α in myogenic cells. Chromatin immunoprecipitation (ChIP) was performed in C2C12 myoblasts (under different
culture conditions) using a p38α-specific antibody. a Non-proportional 2-way Venn diagram showing the number of promoters bound by p38α in the
two experimental conditions: proliferation (GM) and 24 h of differentiation (24 h DM). b Clustering analysis of genes bound by p38α in GM and 24 h DM.
Genes were grouped in five clusters according to the pattern of binding along the promoter. Cluster 1 is enriched in transcription factors, developmental
regulators, and muscle-related genes. Cluster 2 is enriched in genes involved in bone development, developmental regulators, and transcription factors
and cluster 3 includes miscellaneous genes. Cluster 4 is enriched in sensory perception and olfactory receptors whereas cluster 5 is enriched in protein
transport, phosphorylation, and cell cycle-related genes. c Functional annotation analysis of the Gene ontology (GO) of bound genes in GM and 24 h DM
was performed using DAVID. The top annotation clusters are shown according to their enrichment score. Names are based on enriched GO annotations.
d Table showing transcription factor binding sites of p38α-bound genes. Analyses of DNA-binding elements present in promoters were performed using
GSEA. The highest P value element is shown. Unknown binding elements have been omitted
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identified 46 genes bound by p38α that were upregulated
in SB-treated C2C12 myoblasts, and 70 genes bound
and downregulated in similar C2C12 cell culture condi-
tions. Of these, only 10 and 12 genes were also up- and
downregulated, respectively, in p38α-deficient satellite
cells (Fig. 6a, b). Furthermore, GO analysis of the genes
bound and regulated by p38α in differentiating C2C12
cells showed that they are mainly involved in signal
transduction pathways, response to hypoxia, homeostatic
processes, and cell proliferation. On the other hand,
GO analysis of genes bound by p38α and upregulated
when p38α activity was chemically inhibited showed
enrichment for transcription factors and nuclear re-
ceptor coactivators (Fig. 6c). Interestingly, DAVID
analysis of canonical pathways enriched in genes bound
by p38α highlighted the Wnt signaling pathway as the
main signaling module regulated by p38α (Fig. 6d).
We validated p38α binding to the promoters of genes
up- or downregulated after p38 inactivation in myogenic
cells belonging to the different GO categories and path-
ways described above: Wnt signaling pathway (Wnt9a),
actin cytoskeleton organization (Dock1), cellular signal-
ing (RhoU, Kitl and Skil), and regulation of transcription
(Spry1). This validation was performed through ChIP of
cells cultured in three different conditions (GM, 24, and
48 h DM—this latter time-point was included to extend
the kinetics of p38α binding), and subsequent semiquan-
titative or qPCR analysis of the immunopurified DNA
(Fig. 7a, b). Moreover, and consistent with previously pub-
lished results [15, 21], we found that p38α recruitment to
Myog and Pax7 promoters is increased upon differentiation
(Fig. 7c). Of note, actual recruitment of the muscle regula-
tory factor MyoD (but not Mef2) to the newly identified
p38α targets Wnt9a and RhoU in differentiating C2C12
myoblasts was confirmed by ChIP-qPCR (Fig. 7d, e).
Discussion
During myogenesis, satellite cells need to cease prolifera-
tion and initiate differentiation as a key step to fuse and
form multinucleated myotubes. In vivo, this is the cen-
tral step for the success of the tissue regeneration
process in response to injury (i.e., forming new myofi-
bers to repair the damaged muscle tissue). Previous
studies had shown that the proliferation-to-differentiation
transition of myoblasts (derived from satellite cells or
from immortalized myogenic cell lines) requires timely ac-
tivation of p38αMAPK (reviewed in [3, 4, 7, 9]), being this
isoform also needed for proper muscle regeneration in
mice [25]. Interestingly, this isoform was also shown to
play an important role in muscular dystrophy progression
Fig. 5 The kinase activity is not required for p38α recruitment to chromatin. p38α-bound promoters in full chromosome 11 and the promoter of
Wnt9a, one of the p38α-regulated genes, as an example of the general increased occupancy signal observed on promoters when cells were
treated with the SB203580 p38α/β inhibitor. UCSC genome browser with overimposed binding signal is shown
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in mice [36]. Here, we show that p38α exerts this myo-
genic function at least in part via binding and acting at
chromatin. By genome-wide localization analysis coupled
to gene expression profiling, we found this p38 isoform
associated with mammalian loci more frequently than in
any study previously published. In particular, p38α associ-
ated with chromatin during the myoblast proliferation-to-
differentiation transition, and this correlated with the high
Fig. 6 Identification of genes bound and regulated by p38α. a, b The two data sets (expression array and ChIP-on-chip) were crossed to identify
genes bound and regulated by p38α. The non-proportional 2-way Venn diagrams show that, at 24 h of differentiation (DM), p38α binds to the
promoter of 46 genes upregulated in SB-treated C2C12 cells (a) and to 70 genes downregulated in myoblasts lacking active p38α (b). Only 10
and 12 of these bound genes are also upregulated and downregulated, respectively, in p38α-deficient satellite cells. c Gene ontology analysis of
genes bound and regulated by p38α in C2C12 cells at 24 h in DM. Enriched GO annotations of genes downregulated in SB-treated C2C12 myoblasts
are shown in green whereas enriched GO annotations of upregulated genes are shown in red. d DAVID analysis of canonical pathways enriched in
genes bound by p38α showed that Wnt signaling pathway was one of the main signaling modules regulated by p38α. KEGG pathway is shown with
p38α-bound promoters highlighted
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levels of transcription, supporting the relevance of kinase
signaling pathways in directly regulating transcription, in
agreement with previous reports [37–40]. At variance
with the classical view of p38α as a positive regulator
of transcription [12, 41], we also found that the p38α-
chromatin binding was not always associated with active
transcription during this myogenic transition, since
many p38α-bound promoters were transcriptionally
inactive or repressed. Thus, p38α is recruited to a large set
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Input p38αIgG
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Fig. 7 Validation of p38α binding at several identified targets. a Proliferating (GM) or differentiating (24 and 48 h DM) C2C12 cells were subjected to
ChIP analysis with antibodies to p38α or control rabbit IgG. Immunopurified DNA was subjected to semiquantitative PCR with indicated primers, and
the PCR products were then run on an agarose gel. Representative images are shown. Densitometry of the bands was measured using ImageJ and
normalized to input. b, c DNA from C2C12 cells was immunopurified as in (a) and then subjected to qPCR analysis with indicated primers. Data show
the relative recruitment of p38α at these promoters and represent the mean of three independent experiments ± SEM. Non-parametric Mann–Whitney
U test was used to assess statistical significance (P value <0.05). d, e Proliferating (GM) or differentiating (24 and 48 h DM) C2C12 cells were subjected
to ChIP analysis with antibodies to MyoD, Mef2 or control rabbit IgG and immunopurified DNA was subjected to qPCR analysis with indicated primers
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or repression, hence pointing to more complex regulatory
mechanisms than previously anticipated.
How is p38α recruited to muscle loci is not known,
but it likely involves interaction with chromatin-
regulatory and/or transcription factors, as demonstrated
for several stress-induced genes [42]. Of interest, p38α-
bound promoters are enriched with binding motifs for
several transcription factors, principally Sp1, Tcf3/E47,
Lef1, FoxO4, MyoD, and NFATc, which are known to be
phosphorylation substrates of p38 MAPK. In skeletal
myoblasts, in particular, p38α associates with MyoD and
E47 [12, 15] transcription factors, and specific phosphor-
ylation of E47 promotes E47/MyoD dimerization, bind-
ing to muscle-specific loci and initiation of gene
expression [12]. Likewise, phosphorylation of MEF2 by
p38 facilitates both recruitment of MyoD and expression
of late myogenic genes, in a feed-forward mechanism
[11], and of ASH2L-MLL methyltransferase complex
[18, 19]. p38α also phosphorylates Baf60c allowing
SWI/SNF-mediated chromatin remodeling at muscle-
specific loci [15–17]. Interestingly, p38α was also shown
to represses Pax7 gene expression via direct Ezh2 phos-
phorylation, as an indispensable event for the transition of
proliferating myoblasts into their differentiating state [21].
Thus, p38α may help both silence proliferation-associated
genes and activate differentiation-promoting genes at this
transition, by directly targeting negative and positive epi-
genetic and/or transcriptional regulators. Because the p38
MAPK homolog Hog1 targets the RNA Pol II machinery
and induces chromatin remodeling at stress-responsive
loci in yeast [43], it is possible that p38α regulates Pol II-
dependent gene transcription in mammalian myogenesis
in a similar way. It is worth noting that p38 was also
found on a subset of genes independently of its kin-
ase activity. Our work adds to several recent studies
of protein kinases that bind and act on chromatin:
extracellular signal-regulated kinase (ERK), cJun N-
terminal kinase (JNK), the MSK, AMPK, and Dyrk1A [37,
38, 44–46]. This study also complements the previously
described association of p38/Hog1 to osmostress genes to
mediate adaptation to extracellular changes in mammals
and yeast [26, 27, 42].
Of interest, we observed slower muscle differentiation
kinetics in C2C12 myoblasts compared to satellite cells
in culture; although the underlying causes for this differ-
ence are not clear, they may relate to the distinct nature
of both cell types (freshly isolated cells versus immortal-
ized cells) and the different velocity of p38α activation in
both cell types (see Fig. 1a). Whether the expression of
the identified p38α-regulated late genes depends on
the early ones, according to the proposed temporal
regulation of muscle gene expression through a MyoD-
mediated feed-forward circuit involving p38 MAPK [11],
is not yet known.
Finally, although the nature of p38α-regulated genes
encompasses several categories, DAVID analysis of canon-
ical pathways enriched in genes bound by p38α showed
the Wnt pathway as the main signaling module regulated
by p38α. Consistent with this, MyoD was found to be
recruited to the newly identified p38α target Wnt9a, in
addition to muscle-specific gene promoters, as expected.
This is worth highlighting based on the reported relevant
role of canonical and non-canonical Wnt signaling in
distinct satellite cell functions in vivo (expansion, switch-
ing from proliferation to differentiation or cell motility)
[47–49]. Taken together, this study increases our under-
standing on how p38 MAPK regulates gene expression
during myogenesis, and greatly enlarges the number and
nature of target genes downstream of p38α activation.
Notably, through this analysis, we have become aware of
new categories of genes whose repression depends on
p38α both in proliferating and differentiating conditions,
expanding, yet complicating, the function of p38α as a
negative regulator of muscle gene transcription. It is pos-
sible that comparable principles of chromatin binding and
activity might be relevant for other kinases.
Conclusions
Collectively, through this study, we demonstrate associ-
ation and action of p38α MAPK throughout chromatin
uncovering new classes of target genes during the transi-
tion of myoblasts from proliferation to differentiation.
The recruitment of p38α to large sets of gene promoters
appears to facilitate their activation or repression during
this process. This is consistent with this MAPK isoform
being a transcriptional regulator.
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